{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T15:45:26Z","timestamp":1720712726905},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","worldneurosurgery.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.wneu.2017.02.068","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T16:06:07Z","timestamp":1489161967000},"page":"816.e11-816.e16","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A Case of Therapy-Related Acute Myeloid Leukemia Associated with Adjuvant Temozolomide Chemotherapy for Anaplastic Astrocytoma"],"prefix":"10.1016","volume":"101","author":[{"given":"Kenzo","family":"Kosugi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukina","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2017.02.068_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2017.02.068_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-008-9764-5","article-title":"Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia","volume":"93","author":"Chamberlain","year":"2009","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2017.02.068_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/neuonc\/nos068","article-title":"Treatment-related myelodysplasia in patients with primary brain tumors","volume":"14","author":"Baehring","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2017.02.068_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/A:1006175831785","article-title":"Acute leukemia following treatment of malignant glioma","volume":"40","author":"Perry","year":"1998","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2017.02.068_bib5","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1986.4.12.1748","article-title":"Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features","volume":"4","author":"Kantarjian","year":"1986","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2017.02.068_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood.V58.4.759.759","article-title":"Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease","volume":"58","author":"Rowley","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2017.02.068_bib7","first-page":"144","article-title":"Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors","volume":"71","author":"Takeyama","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.wneu.2017.02.068_bib8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2017.02.068_bib9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/WNL.57.2.340","article-title":"Temozolomide chemotherapy in recurrent oligodendroglioma","volume":"57","author":"van den Bent","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2017.02.068_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1011878214861","article-title":"Therapy-related myelodysplastic syndrome (t-MDS) in a patient with anaplastic astrocytoma: successful treatment with allogeneic bone marrow transplant","volume":"53","author":"Rogers","year":"2001","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2017.02.068_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.leu.2403187","article-title":"Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML","volume":"18","author":"Schoch","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.wneu.2017.02.068_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/ctrv.2000.0186","article-title":"Treatment-related leukaemia\u2014a clinical and scientific challenge","volume":"26","author":"Ng","year":"2000","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.wneu.2017.02.068_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11060-004-2028-0","article-title":"Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma","volume":"71","author":"Su","year":"2005","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2017.02.068_bib14","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00277-005-1093-6","article-title":"Secondary Ph+ acute lymphoblastic leukemia after temozolomide","volume":"84","author":"De Vita","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.wneu.2017.02.068_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1215\/15228517-2006-003","article-title":"Treatment-related myelodysplasia\/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literature","volume":"8","author":"Noronha","year":"2006","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2017.02.068_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/MPH.0b013e318182e74f","article-title":"Treatment-related myelodysplastic syndrome after temozolomide use in a child: first report","volume":"30","author":"Dufour","year":"2008","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.wneu.2017.02.068_bib17","first-page":"392","article-title":"Therapy-related myelodysplastic syndrome\/acute myeloid leukemia after treatment with temozolomide in a patient with glioblastoma multiforme","volume":"39","author":"Kim","year":"2009","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.wneu.2017.02.068_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/1752-1947-4-274","article-title":"Acute lymphoblastic leukemia subsequent to temozolomide use in a 26-year-old man: a case report","volume":"4","author":"Shaikh","year":"2010","journal-title":"J\u00a0Med Case Rep"},{"key":"10.1016\/j.wneu.2017.02.068_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/pbc.22542","article-title":"Acute lymphoblastic leukemia after Temezolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation","volume":"55","author":"Momota","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.wneu.2017.02.068_bib20","doi-asserted-by":"crossref","first-page":"760402","DOI":"10.1155\/2010\/760402","article-title":"Temozolomide-induced myelodysplasia","volume":"2010","author":"Natelson","year":"2010","journal-title":"Adv Hematol"},{"key":"10.1016\/j.wneu.2017.02.068_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2141.2011.08641.x","article-title":"Temozolomide may induce therapy-related acute lymphoblastic leukaemia","volume":"154","author":"Ogura","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.wneu.2017.02.068_bib22","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/neuonc\/not036","article-title":"Secondary hematological malignancies associated with temozolomide in patients with glioma","volume":"15","author":"Momota","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2017.02.068_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jocn.2013.07.032","article-title":"Temozolomide-related acute lymphoblastic leukemia with translocation (4;11)(q21;q23) in a glioblastoma patient","volume":"21","author":"Chou","year":"2014","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2017.02.068_bib24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.47102\/annals-acadmedsg.V43N6p334","article-title":"Treatment-related acute myeloid leukaemia after temozolomide for glioblastoma multiforme","volume":"43","author":"Tan","year":"2014","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.wneu.2017.02.068_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jocn.2013.03.039","article-title":"Long-term treatment with temozolomide in malignant glioma","volume":"21","author":"Mannas","year":"2014","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2017.02.068_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2310\/7290.2010.00002","article-title":"Patient-tailored, imaging-guided, long-term temozolomide chemotherapy in patients with glioblastoma","volume":"9","author":"Galldiks","year":"2010","journal-title":"Mol Imaging"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875017302413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875017302413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T18:47:09Z","timestamp":1658774829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875017302413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":26,"alternative-id":["S1878875017302413"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2017.02.068","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Case of Therapy-Related Acute Myeloid Leukemia Associated with Adjuvant Temozolomide Chemotherapy for Anaplastic Astrocytoma","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2017.02.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}